GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » Long-Term Capital Lease Obligation

Vicplas International (SGX:569) Long-Term Capital Lease Obligation : S$12.5 Mil (As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Vicplas International Long-Term Capital Lease Obligation?

Vicplas International's Long-Term Capital Lease Obligation for the quarter that ended in Jan. 2024 was S$12.5 Mil.

Vicplas International's quarterly Long-Term Capital Lease Obligation declined from Jan. 2023 (S$6.6 Mil) to Jul. 2023 (S$5.7 Mil) but then increased from Jul. 2023 (S$5.7 Mil) to Jan. 2024 (S$12.5 Mil).

Vicplas International's annual Long-Term Capital Lease Obligation increased from Jul. 2021 (S$5.1 Mil) to Jul. 2022 (S$7.4 Mil) but then declined from Jul. 2022 (S$7.4 Mil) to Jul. 2023 (S$5.7 Mil).


Vicplas International Long-Term Capital Lease Obligation Historical Data

The historical data trend for Vicplas International's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International Long-Term Capital Lease Obligation Chart

Vicplas International Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 4.11 5.09 7.35 5.73

Vicplas International Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.03 7.35 6.59 5.73 12.49

Vicplas International  (SGX:569) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Vicplas International Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Vicplas International's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicplas International (SGX:569) Business Description

Traded in Other Exchanges
N/A
Address
35 Joo Koon Circle, Singapore, SGP, 629110
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines